LFB Biomanufacturing
Rachel CEPULO is a highly experienced professional who has worked in various roles within the biotechnology and pharmaceutical industry. Rachel has worked as a QA Manager at LFB Biomanufacturing, overseeing the quality management of biotechnological products. Additionally, Rachel has experience in project coordination and management at Genzyme, a Sanofi company, where Rachel led the transfer of biotechnological products between sites. With a background in pharmacy, Rachel has a strong foundation in quality assurance and production management, with a focus on improving quality and operational efficiency. Rachel has a proven track record of success in leading teams and strategic projects, as well as managing audits and deviations to ensure product quality and compliance.
This person is not in any offices
LFB Biomanufacturing
LFB Biomanufacturing is an expert CDMO in the development and manufacture of recombinant proteins via cell culture, with specific know-how in the area of monoclonal antibodies (mAbs). LFB Biomanufacturing supplies a full range of bioproduction services, from the development of cell lines to the manufacturing clinical and commercial batches of active substances from biological products up to multiple pool of 2000L Cell Culture production capacities using Disposable Bioreactors Technology and exclusively Single-Use systems. The Alès site is regulary inspected by Customers as well as Health Agencies, including French-ANSM and US-FDA. LFB Biomanufacturing is subsidiary of the LFB Group.